Clinical Trial Update: Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update assessing screening methods for treating Meibomian Gland Dysfunction, with conditions including chalazion and dry eye syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chalazion
• Dry Eye Syndromes

Snippet

Sponsor: TearScience, Inc. | Conditions: Chalazion, Dry Eye Syndromes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-12-06